Insider Selling: PolyNovo Limited (ASX:PNV) Insider Sells 750,000 Shares of Stock

PolyNovo Limited (ASX:PNVGet Free Report) insider Bruce Rathie sold 750,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of A$2.52 ($1.70), for a total transaction of A$1,887,000.00 ($1,275,000.00).

PolyNovo Price Performance

The company has a debt-to-equity ratio of 21.32, a quick ratio of 1.58 and a current ratio of 3.41.

PolyNovo Company Profile

(Get Free Report)

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound.

Recommended Stories

Receive News & Ratings for PolyNovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PolyNovo and related companies with MarketBeat.com's FREE daily email newsletter.